We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.
TEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty pharmaceutical company focused on the...
TEL AVIV, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty pharmaceutical company focused on the...
TEL AVIV, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the...
TEL AVIV, Israel, April 02, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the...
Reports continued enrollment in the second part of the Phase 3 clinical trial in bunionectomy Remains on track to announce top-line data by mid-2024 TEL AVIV, Israel, March 01, 2024 (GLOBE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.038 | 4.35779816514 | 0.872 | 0.96 | 0.7672 | 29262 | 0.85698752 | CS |
4 | -0.88 | -49.1620111732 | 1.79 | 2.55 | 0.69 | 403844 | 1.41861114 | CS |
12 | -0.99 | -52.1052631579 | 1.9 | 2.55 | 0.69 | 150115 | 1.46353249 | CS |
26 | -1.27 | -58.2568807339 | 2.18 | 3.36 | 0.69 | 84067 | 1.63682317 | CS |
52 | -5.714 | -86.2620772947 | 6.624 | 26.41 | 0.69 | 403261 | 8.41431917 | CS |
156 | -32.69 | -97.2916666667 | 33.6 | 78.4 | 0.69 | 367110 | 21.14776143 | CS |
260 | -65.79 | -98.6356821589 | 66.7 | 78.4 | 0.69 | 330543 | 23.96599637 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions